Perfusion imaging with computed tomography: Brain and beyond

European Radiology, Supplement

Volumn 16, Issue 7, 2006, Pages

  Miles, Kenneth A ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Blood flow; Computed tomography; Contrast material; Image processing; Stroke; Tumor

Indexed keywords

FLUORODEOXYGLUCOSE;

ARTICLE; BENIGN TUMOR; CANCER RADIOTHERAPY; CEREBROVASCULAR DISEASE; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FUNCTIONAL ASSESSMENT; HEAD INJURY; HUMAN; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEUROIMAGING; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; STROKE; SUBARACHNOID HEMORRHAGE; TREATMENT PLANNING; TUMOR VASCULARIZATION; VALIDATION PROCESS;

BRAIN NEOPLASMS; CEREBROVASCULAR DISORDERS; CONTRAST MEDIA; HUMANS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33845431736     PISSN: 16133749     EISSN: 16133757     Source Type: Journal    
DOI: 10.1007/s10406-006-0194-1     Document Type: Article

References (41)

1. Axel L (1980) Cerebral blood flow determination by rapid-sequence computed tomography: Theoretical analysis. Radiology 137:679-686
2. Miles KA, Griffiths M (2003) CT perfusion: A worthwhile enhancement? Br J Radiol 76:220-231
3. Gillard JH, Antoun NM, Burnet NG, Pickard JD (2001) Reproducibility of quantitative CT perfusion imaging. Br J Radiol 74:552-555
4. Cenic A, Nabavi DG, Craen RA et al (2000) A CT method to measure hemodynamics in brain tumors: Validation and application to cerebral blood flow maps. AJNR Am J Neuroradiol 21:462-470
5. Purdie TG, Henderson E, Lee TY (2001) Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. Phys Med Biol 46:3161-3175
6. Pollard RE, Garcia TC, Stieger SM et al (2004) Quantitative evaluation of perfusion and permeability of peripheral tumours using contrast-enhanced computed tomography. Invest Radiol 39:340-349
7. Hattori H, Miyoshi T, Okada J, Yoshikawa K et al (1994) Tumor blood flow measured using dynamic computed tomography. Invest Radiol 29:873-876
8. Gillard JH, Minhas PS, Hayball MP et al (2000) Assessment of quantitative computed tomographic cerebral perfusion imaging with H2(15)O positron emission tomography. Neurol Res 22:457-464
9. Wintermark M, Thiran JP, Maeder P et al (2001) Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: A validation study. AJNR Am J Neuroradiol 22: 905-914
10. Miles KA (2004) Contrast enhancement protocols for cerebral perfusion computed tomography. In: Saini S, Bonomo L, Teasdale E, White R (eds) The year in radiology. Vol. 1, no. 3. Advances in MDCT. Clinical Publishing, Oxford, pp 1-6
11. Miles KA (2003) Perfusion CT for the assessment of tumour vascularity: which protocol? Br J Radiol 76:S36-42
12. Bacharach SL, Libutti SK, Carrasquillo JA (2000) Measuring tumour blood flow with H(2)(15)O: Practical considerations. Nucl Med Biol 27:671-767
13. Miles KA (2004) Brain perfusion: Computed tomography applications. Neuroradiology 46:s194-200
14. Mayer TE, Hamann GF, Baranczyk J et al (2000) Dynamic CT perfusion imaging of acute stroke. AJNR Am J Neuroradiol 21:1441-1449
15. Wintermark M, Reichhart M, Thiran JP et al (2002) Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 5:417-432
16. Wintermark M, Reichhart M, Cuisenaire O et al (2002) Comparison of admission perfusion computed tomography and qualitative diffusion-and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke 33:2025-2031
17. Eastwood JD, Lev MH, Wintermark M et al (2003) Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke. AJNR Am J Neuroradiol 24:1869-1875
18. Wintermark M, van Melle G, Schnyder P et al (2004) Admission perfusion CT: Prognostic value in patients with severe head trauma. Radiology 232:211-220
19. Nabavi DG, LeBlanc LM, Baxter B et al (2001) Monitoring cerebral perfusion after subarachnoid hemorrhage using CT. Neuroradiology 43:7-16
20. Miles KA (2002) Functional computed tomography in oncology. Eur J Cancer 38:2079-2084
21. Jinkins JR, Sener RN (1991) The characteristics of cerebral meningiomas and surrounding tissues on dynamic CT. Neuroradiology 33:499-506
22. Swensen SJ, Viggiano RW, Midthun DE et al (2000) Lung nodule enhancement at CT: Multicenter study. Radiology 214:73-80
23. Dugdale PE, Miles KA (1999) Hepatic metastases: The value of quantitative assessment of contrast enhancement on computed tomography. Eur J Radiol 30:206-213
24. Willett CG, Boucher Y, di Tomaso E et al (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10:145-147
25. Sahani DV, Kalva SP, Hamberg LM et al (2005) Assessing tumour perfusion and treatment response in rectal cancer with multisection CT: Initial observations. Radiology 234:785-792
26. Antoch G, Freudenberg LS, Beyer T et al (2004) To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. J Nucl Med 45 [Suppl 1]:S56-65
27. Semenza GL (2002) HIF-1 and tumour progression: Pathophysiology and therapeutics. Trends Mol Med 8 [4 Suppl]:S62-67
28. Raghunand N, Gatenby RA, Gillies RJ (2003) Microenvironmental and cellular consequences of altered blood flow in tumours. Br J Radiol 76:11-22
29. Aronen HJ, Pardo FS, Kennedy DN et al (2000) High microvascular blood volume is associated with high glucose uptake and tumour angiogenesis in human gliomas. Clin Cancer Res 6:2189-2200
30. Hoekstra CJ, Stroobants SG, Hoekstra OS et al (2002) Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomography. Clin Cancer Res 8:2109-2115
31. Miles KA, Griffiths MR, Keith CJ (2006) Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: A study using quantitative contrastenhanced computer tomography and positron emission tomography. Eur J Nucl Med Mol Imaging 33:22-28
32. Veronesi G, Landoni C, Pelosi G et al (2002) Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases. Br J Cancer 86:1391-1395
33. Fukuda K, Taniguchi H, Koh T et al (2004) Relationships between oxygen and glucose metabolism in human liver tumours: Positron emission tomography using (15)O and (18)F-deoxyglucose. Nucl Med Commun 25:577-583
34. Mankoff DA, Dunnwald LK, Gralow JR et al (2002) Blood flow and metabolism in locally advanced breast cancer: Relationship to response to therapy. J Nucl Med 43:500-509
35. Hermans R. Meijerink M, van den Bogaert W et al (2003) Tumour perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 57:1351-1356
36. 18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys 5:1295-1300
37. Devries AF, Griebel J, Kremser C et al (2001) Tumour microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res 61:2513-2516
38. Oku S, Nakagawa K, Momose T et al (2002) FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer. Ann Nucl Med 16:409-416
39. Herbst RS, Mullani NA, Davis DW et al (2002) Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin. J Clin Oncol 20:3804-3814
40. Mankoff DA, Dunnwald LK, Gralow JR et al (2003) Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. J Nucl Med 44:1806-1814
41. Kurdziel KA, Figg WD, Carrasquillo JA et al (2003) Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer. Mol Imaging Biol 5:86-93